Table 3.
Care Outcomes of Patients Receiving HFNC Oxygen Therapy on GIM Wards
| Outcome | N=124 |
|---|---|
| In-hospital death | 18 (14.5%) |
| Admission to critical care (ICU) | 85 (68.5%) |
| Re-admission to ICU* | 9 (10.7%) |
| Hospital length of stay in days, median (IQR) | 15 (10 to 27.5) |
| ICU length of stay in days, median (IQR) | 7 (4 to 15) |
| Cardiac arrest outside ICU | 1 (0.8%) |
| Intubation on arrival in ICU* | 8 (9.4%) |
| Mechanical ventilation* | 40 (47.1%) |
| Acute pulmonary embolism/deep vein thrombosis | 10 (8.1%) |
| Palliative care consult | 12 (9.7%) |
| Discharge destination† | |
| Home | 65 (61.3%) |
| Rehabilitation hospital | 18 (17.0%) |
| Other acute care hospital | 11 (10.4%) |
| Palliative care unit | 6 (5.7%) |
| Transitional care unit | 5 (4.7%) |
| Long-term care unit | 1 (0.9%) |
*Denominator is the number of patients that were treated with HFNC oxygen therapy on GIM wards that required ICU admission (N=85)
†Denominator is the total number of patients that were discharged alive from the hospital (N=106)
HFNC, high-flow nasal cannula oxygen therapy; GIM, general internal medicine; IQR, interquartile range; ICU, intensive care unit